J Korean Med Sci.  2020 Apr;35(16):e162. 10.3346/jkms.2020.35.e162.

Letter to the Editor: How Did We Solve the Risk of Cross-Infection after Testing by the Walk-Through System Pointed Out by Many Authors?

• Kim SI
• Lee JY

• KMID: 2500206
• DOI: http://doi.org/10.3346/jkms.2020.35.e162

Reference

1. Kim SI, Lee JY. Walk-through screening center for COVID-19: an accessible and efficient screening system in a pandemic situation. J Korean Med Sci. 2020; 35(15):e154. PMID: 32301300.

2. Lee J. COVID-19 screening center: how to balance between the speed and safety? J Korean Med Sci. 2020; 35(15):e157. PMID: 32301302.

3. Kim KM, Han SH, Yoo SY, Yoo JH. Potential hazards of concern in the walk-through screening system for the corona virus disease 2019 from the perspective of infection preventionists. J Korean Med Sci. 2020; 35(15):e156. PMID: 32301301.

4. Kym S. Fast screening systems for COVID-19. J Korean Med Sci. 2020; 35(15):e153. PMID: 32301299.

5. Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings. Updated 2020. Accessed March 23, 2020. https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html.

6. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005; 54(RR-17):1–141.

7. Oxivir® Tb RTU. Accessed March 22, 2020. http://solutionsdesignedforhealthcare.com/solutions/products/disinfectants/oxivir-tb-rtu.

8. Sehulster L, Chinn RY. CDC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003; 52(RR-10):1–42.